On one hand, IFN-γ, by upregulating MHC molecules and activating tumor antigen processing and presentation machinery60–64, promotes anti-tumor immunity; on the other hand, it can also suppress anti-tumor immunity by inducing various regulatory mechanisms such as PD-L1 upregulation in stromal and tumor cells65. This evidence concerns the gene CD274 and neoplasm.